Dr. Scott G. Hubosky, MD

Dr. Hubosky practices at Jefferson Division of Psychiatry and Human Behavior - HOPD in Philadelphia, Pennsylvania.

Dr. Hubosky's NPI, 1669451605, was assigned on January 10, 2006. Dr. Hubosky holds Pennsylvania license MD418794.

Dr. Hubosky's primary practice is Jefferson Division of Psychiatry and Human Behavior - HOPD, at 833 Chestnut St, Philadelphia, PA 19107.

Dr. Hubosky's primary practice is Jefferson Division of Psychiatry and Human Behavior - HOPD in Philadelphia, Pennsylvania. Dr. Hubosky is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Jefferson University Physicians. Dmand AI also links Dr. Hubosky to 2 more hospitals and 1 group practice or clinic, each named with a free account. Dr. Hubosky's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hubosky practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Hubosky's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Hubosky is licensed in Pennsylvania.

CMS data shows 1,197 Medicare services from Dr. Hubosky across 16 procedure codes in 2024, for 408 Medicare patients. Medicare paid $115,847 for them.

CMS counts 408 Medicare patients who saw Dr. Hubosky in 2024. The largest group is 65 to 74, with 179 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hubosky's median patient age at 69, with 48% women.

In 2024, Dr. Hubosky wrote 841 Medicare Part D claims for 237 patients. 97% of them were for generic drugs. CMS names the drug for 747 of them, across 13 drugs with 11 or more claims each, at $15,581 in total drug cost. In 2023, CMS named 644 claims across 12 drugs.

Dr. Hubosky accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hubosky as offering telehealth.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 27 papers to Dr. Hubosky, published from 2010 to 2022. 2015 was the busiest year, with 5. The most frequent topics are Carcinoma, Transitional Cell, Ureteroscopy and Ureter. Dr. Hubosky has published most often in J Endourol. Dr. Hubosky's most frequent co-authors are Kelly A. Healy, MD, Ryan Christopher Cleary, MD and Chandan R. Kundavaram, MD.

CMS Open Payments shows 97 general payments to Dr. Hubosky from 15 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 53% of the total. C. R. Bard, Inc. & Subsidiaries paid the most, $20,031. It also lists 1 research payment totaling $352 in 2020.